Drug: Ziconotide: chronic pain clinical trials
Registry records that list "Drug: Ziconotide" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
6
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
6 trials, 1 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy NCT07499882 | Not yet recruiting | United States | Christian Hospital Northeast Northwest | 2026-05-02 | |
| Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy NCT01992562 | Withdrawn | Phase 4 | United States | Aaron Boster | 2014-01 |
| Patient Registry of Intrathecal Ziconotide Management(PRIZM) NCT01888120 | Completed | United States | Jazz Pharmaceuticals | 2013-07 | |
| Intrathecal Bolus Doses of Ziconotide NCT01373983 | Completed | Phase 4 | Sweden | University Hospital, Linkoeping | 2011-08 |
| Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain NCT00076544 | Completed | Phase 3 | United States | Elan Pharmaceuticals | 2004-02 |
| A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain NCT00002160 | Completed | Phase 2 | United States | Neurex |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.